LEP

Vestaron and Simplot Grower Solutions Forge Strategic Distribution Partnership to Deliver Novel Sustainable Solutions for Farmers

Retrieved on: 
Wednesday, March 27, 2024
LEP, Farmer, SPEAR, Face, PHI, Vegetable, Partnership, Agriculture, Biodiversity, Marketing, MRL, Product management, IPM, Insecticide, REI

This strategic collaboration brings together Vestaron's novel insecticides and Simplot Grower Solutions’ extensive network and agronomic expertise, to deliver sustainable and effective crop protection solutions to farmers across the country.

Key Points: 
  • This strategic collaboration brings together Vestaron's novel insecticides and Simplot Grower Solutions’ extensive network and agronomic expertise, to deliver sustainable and effective crop protection solutions to farmers across the country.
  • By joining forces with Vestaron, Simplot Grower Solutions aims to enhance its portfolio of sustainable solutions, providing farmers with access to cutting-edge technologies that contribute to both productivity and environmental stewardship.
  • Dean Williams, Head of Product Management for Simplot Grower Solutions, commented, “Simplot is proud to partner with Vestaron in our aligned commitment to deliver the leading biological crop protection solutions our farmer customers require.
  • Nationwide Reach: Simplot Grower Solutions’ widespread network will ensure that SPEAR LEP insecticide will reach farmers across the United States, promoting accessibility and adoption.

Vestaron bioinsecticide receives emergency use authorization in Greece for control of devastating tomato leafminer infestations

Retrieved on: 
Wednesday, February 7, 2024
Plant, Peptide, SPEAR, Neonicotinoid, Environment, IRAC, Central nervous system, Bacillus thuringiensis, Pesticide, LEP, Farmer, Risk, Rotation, Insecticide, Leaf, Agriculture

Durham, North Carolina, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vestaron Corporation has been granted an Article 53 Emergency Authorization to provide farmers in Greece with access to a novel bioinsecticide that tackles devastating infestations of tomato leafminer (Tuta absoluta) while presenting minimal risk to beneficials, pollinators, or people.

Key Points: 
  • Durham, North Carolina, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vestaron Corporation has been granted an Article 53 Emergency Authorization to provide farmers in Greece with access to a novel bioinsecticide that tackles devastating infestations of tomato leafminer (Tuta absoluta) while presenting minimal risk to beneficials, pollinators, or people.
  • This authorization in Greece marks a significant commercial milestone for Vestaron and paves the way for its first sales in Europe.
  • Agricultural product distributor Oxygen AgroShield LP petitioned the Greek Ministry of Agriculture for emergency authorization on behalf of 19 other Greek grower groups.
  • Oxygen AgroShield said it was delighted that the temporary authorization had been granted, giving tomato growers the chance to effectively and sustainably control costly tomato leafminer infestations.

Vestaron announces CEO transition, appoints Juan Estupinan as Interim CEO

Retrieved on: 
Thursday, February 1, 2024
Durata Therapeutics, MRL, Growth, Research, REI, Biodiversity, Abbott Laboratories, PHI, Environment, CPA, Management, Therapy, Laboratory, Farmer, Accounting, LEP

Juan Estupinan, Chief Financial Officer, has been named the company’s interim CEO and President, effective immediately.

Key Points: 
  • Juan Estupinan, Chief Financial Officer, has been named the company’s interim CEO and President, effective immediately.
  • Mr. Estupinan brings extensive financial and business leadership experience across multiple industries and is well-positioned to progress the company’s strategic vision and priorities.
  • “Vestaron had a strong finish in 2023 and is well positioned for continued growth in our focus markets in 2024.
  • The Board is aligned and confident in Vestaron’s long-term success, its financial stability, and is fully supportive of Mr. Estupinan and the entire Vestaron team in executing on our strategic vision.”
    Juan Estupinan joined Vestaron as Chief Financial Officer in May of 2022.

Leavitt Equity Partners Closes $180 Million Fund III, Surpassing $150 Million Target

Retrieved on: 
Friday, January 5, 2024
Professional Services, Finance, Policy, Growth, LEP, Dorsey & Whitney, Insurance

Leavitt Equity Partners (“LEP”), a value-add healthcare focused private equity firm, today announced the closing of its third fund, Leavitt Equity Partners III (“LEP III”).

Key Points: 
  • Leavitt Equity Partners (“LEP”), a value-add healthcare focused private equity firm, today announced the closing of its third fund, Leavitt Equity Partners III (“LEP III”).
  • LEP III raised over $180 million, surpassing the investment firm’s initial target of $150 million.
  • LEP III’s Limited Partner base consists primarily of strategic healthcare partners, in addition to insurance companies, foundations, and family offices.
  • Dorsey & Whitney served as legal advisors to Leavitt Equity Partners in the formation of LEP III.

AMN Healthcare Study Tracks 45 Languages Spoken in Patient/Provider Encounters in U.S.

Retrieved on: 
Tuesday, November 14, 2023
American Sign Language, Mandarin, Violence, Acquisition, ASL, Civil Rights Act, AHRQ, Language, Risk, Congo, Vietnamese, Patient, Agency, AMN, Amharic, United States Census Bureau, LEP, Hospital, Deafness, Democratic republic, Health care, Film industry, Health insurance

The new report is based on more than 204 million minutes – or more than 142,000 days -- of language interpretation services the company provided via AMN Healthcare Language Services for patients in hospitals, medical groups, and other clinical settings. That’s compared to 102 million minutes when AMN Healthcare compiled its inaugural report in 2021, a 100 percent increase in interpretation services provided.

Key Points: 
  • That’s compared to 102 million minutes when AMN Healthcare compiled its inaugural report in 2021, a 100 percent increase in interpretation services provided.
  • “Language diversity in healthcare is exploding,” said Jacobia Solomon, President of AMN Healthcare Language Services.
  • Spanish is the most commonly spoken language other than English in patient/provider encounters in 48 states, according to the report.
  • “Languages used in patient/provider healthcare encounters generally are regionalized based on migration patterns to the U.S.” Solomon said.

Full Circle Lithium Achieves 99%+ Lithium Recovery At Its First Deployed Demo Plant Representing A Significant Industry Extraction Milestone

Retrieved on: 
Tuesday, October 24, 2023
Lithium, DLE, Filtration, Absorption, TLG, FCL, LEP, LIVE, The Company, Recycling, Option

The successful results of FCL's demonstration plant to date mark a major milestone for FCL and the wider lithium extraction and recycling industry.

Key Points: 
  • The successful results of FCL's demonstration plant to date mark a major milestone for FCL and the wider lithium extraction and recycling industry.
  • The FCL Demo Plant utilizing proprietary extraction and processing technology (or "LEP" technology, which is a form of direct lithium extraction or "DLE"), has now been operating for several weeks.
  • The FCL Demo Plant has successfully extracted over 99% of the lithium from ChemicalCo1's lithium effluent in multiple cycles.
  • We believe that this is a key achievement in the lithium extraction industry," said Carlos Vicens, CEO of FCL.

CERTIFIED LANGUAGES INTERNATIONAL LAUNCHES PROPRIETARY VIDEO INTERPRETING PLATFORM

Retrieved on: 
Tuesday, October 10, 2023
Mobile, Organization, Language, Education, HIPAA, LEP, VRI, CLI, Merfy, Insurance, ASL, Patient, American Sign Language, Mobile phone

PORTLAND, Ore., Oct. 10, 2023 /PRNewswire/ -- Certified Languages International (CLI), a leader in the remote interpretation and language services industry, announces the rollout of MERFi™, a proprietary video remote interpreting (VRI) platform, effectively migrating its existing clientele from a third-party VRI service in use since 2013. The embodiment and natural evolution of CLI's highest-quality language access services, MERFi (Mobile, Easy, Reliable, Fast Interpreting) connects users with top-tier video interpreters with the customizations, reliability, and flexibility to provide full-spectrum support. MERFi is HIPAA compliant, secure, and offers video interpreters in 21 spoken languages plus American Sign Language (ASL). Users can also access phone interpreters in 230+ spoken languages with the platform's audio feature. 

Key Points: 
  • PORTLAND, Ore., Oct. 10, 2023 /PRNewswire/ -- Certified Languages International (CLI), a leader in the remote interpretation and language services industry, announces the rollout of MERFi™, a proprietary video remote interpreting (VRI) platform, effectively migrating its existing clientele from a third-party VRI service in use since 2013.
  • The embodiment and natural evolution of CLI's highest-quality language access services, MERFi (Mobile, Easy, Reliable, Fast Interpreting) connects users with top-tier video interpreters with the customizations, reliability, and flexibility to provide full-spectrum support.
  • MERFi is HIPAA compliant, secure, and offers video interpreters in 21 spoken languages plus American Sign Language (ASL).
  • MERFi, an integrated video solution, allows users to seamlessly place video, audio, and multiparty calls through the same web-based device-agnostic platform, significantly benefiting companies and their clientele of limited English proficient (LEP), deaf, and hard-of-hearing individuals.

United States Commission on Civil Rights Releases Report: The Federal Response to Anti-Asian Racism in the United States

Retrieved on: 
Wednesday, September 27, 2023
Commissioner, Hatred, Left–right political spectrum, Racism, Commission, COVID-19, Fear, NIBRS, Data collection, Advisory Committee of U.S. Attorneys, Research, Multimedia, Language, Person, Congress, United, Federal Response, FBI, Crime, LEP, Civil and political rights, Cryptocurrency, Drug, Financial adviser, Private investigator, Asian Americans

WASHINGTON, Sept. 27, 2023 /PRNewswire/ -- Today, the United States Commission on Civil Rights releases the report , The Federal Response to Anti-Asian Racism in the United States.

Key Points: 
  • WASHINGTON, Sept. 27, 2023 /PRNewswire/ -- Today, the United States Commission on Civil Rights releases the report , The Federal Response to Anti-Asian Racism in the United States.
  • "Ultimately, the absence of adequate performance metrics poses a significant challenge in assessing the federal government's effectiveness in combating the surge in hate crimes against the Asian community.
  • The U.S. Commission on Civil Rights is the only independent, bipartisan agency charged with advising the President and Congress on civil rights and reporting annually on federal civil rights enforcement.
  • Our 56 state and territory Advisory Committees offer a broad perspective on civil rights concerns at state and local levels.

Cutaneous Lupus Erythematosus Market Insight & Forecast Reveals USD 1.2 Billion Growth Potential by 2032 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 31, 2023
General Health, Pharmaceutical, Health, Other Health, EU4, DLE, Histology, Education, LET, Classification, Biogen, Epidemiology, Lupus, Bristol Myers Squibb, Acute cutaneous lupus erythematosus, Cancer, Research, SLE, Risk, USD, CLE, Diagnosis, Deucravacitinib, Horizon Therapeutics, Systemic disease, Nature, Immunoglobulin G, TYK2, LEP, LE, BDCA2, Vaccine, Medical device, Pharmaceutical industry, Medical imaging, Skin

The "Cutaneous Lupus Erythematosus Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cutaneous Lupus Erythematosus Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.
  • In 2022, the Cutaneous Lupus Erythematosus market in the 7MM and China was approximately USD 580 million, expected to reach USD 1.2 billion by 2032.
  • Notably, Biogen's litifilimab and Bristol Myers Squibb's deucravacitinib will lead the Cutaneous Lupus Erythematosus market in the forecast period.
  • In 2022, the total market size of Cutaneous lupus erythematosus in the 7MM and China was ~USD 580 million, expected to reach ~USD 1,260 million by 2032.

EQS-News: Vulcan Energy Resources Limited: Positive local development and permitting progress towards delivery of Phase One of Vulcan’s Zero Carbon Lithium™ Project

Retrieved on: 
Thursday, July 13, 2023
Lithium, Carbon, Hoechst, Communication, State, Lord, Life, VUL, FSE, CDO, CLP, City, Phase 1, Water, LEP, Commercial property

The G-LEP construction is planned as part of Phase One of Vulcan’s Zero Carbon Lithium™ Project in the Upper Rhine Valley Brine Field.

Key Points: 
  • The G-LEP construction is planned as part of Phase One of Vulcan’s Zero Carbon Lithium™ Project in the Upper Rhine Valley Brine Field.
  • Vulcan plans to extract carbon neutral lithium and supply carbon neutral, renewable heat to the city, as part of its Phase One development.
  • We have worked closely with local stakeholders to progress our Zero Carbon Lithium™ Project plans.
  • Our hard work is paying off, with positive decisions for the Project provided by the Landau City Council and the surrounding planned Phase One project locations.